Investigation of Prohibitin Levels in Preeclampsia Cases: A Case Control Study from a Tertiary Hospital

dc.contributor.authorKeser, Hasan Burak
dc.contributor.authorBulmuş, Funda Gülcü
dc.contributor.authorKavak, Salih
dc.contributor.authorKavak, Ebru Çelik
dc.date.accessioned2026-08-12T15:01:13Z
dc.date.issued2025
dc.departmentFırat Üniversitesi
dc.description.abstractIntroductıon: To evaluate the relationship between the effects of prohibitin at the cellular level and the pathophysiology of preeclampsia. Methods: This study included a total of 120 patients who presented to our clinic at 20–41 weeks of gestation. The participants were divided into three groups: 40 pregnant women with preeclampsia with severe features, 40 pregnant women with preeclampsia, and 40 healthy pregnant women. To measure serum prohibitin levels, 10 cc of venous blood was collected from each participant, and comparisons were made between the groups. Results: Serum prohibitin levels were significantly higher in pregnant women with preeclampsia with severe features and preeclampsia compared to the control group (p
dc.identifier.doi10.5505/achmedj.2025.08379
dc.identifier.endpage21
dc.identifier.issn2822-5872
dc.identifier.issue1
dc.identifier.startpage15
dc.identifier.urihttps://doi.org/10.5505/achmedj.2025.08379
dc.identifier.urihttps://hdl.handle.net/11508/26235
dc.identifier.volume4
dc.language.isoen
dc.publisherAnkara Şehir Hastanesi
dc.relation.ispartofACH Medical Journal
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_DergiPark_20260511
dc.subjectOne Health
dc.subjectTek Sağlık
dc.titleInvestigation of Prohibitin Levels in Preeclampsia Cases: A Case Control Study from a Tertiary Hospital
dc.typeArticle

Dosyalar